MedPage Today on MSN
Chemo-free regimen may be effective option for EGFR-mutant lung cancer
Phase II study shows promise in setting of third-generation EGFR TKI resistance ...
Vaxcyte stays a Strong Buy after VAX-31 phase 3 OPUS-1 success; broader pneumococcal coverage and 2027 catalysts are ahead.
In early October 2026, news spread across the world that “a 28-year-old female employee working at a plague research ...
Three “enhanced” flu vaccines are designed to better protect seniors. The American Academy of Family Physicians urges them to ...
The number of people sick with flu is starting to increase across the United States, with health authorities warning that in ...
The number of people sick with flu is starting to increase across the United States, with health authorities warning that in some western regions of ...
On Tuesday, Pacific Biosciences of California, Inc. (PACB), a developer of advanced sequencing technologies, and TychoBio, an AI drug discovery company, announced a collaboration to generate ...
City officials announced late Tuesday that the frozen zone around the unstable Manhattan building has been reduced, allowing some pedestrians and traffic back into the area. Ahmed Tigani, commissioner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results